V Rickerts1, H Brodt, S Staszewski, W Stille. 1. Klinikum der J.W. Goethe Universität Frankfurt, Med. Klinik III / Infektiologie, Theodor-Stern-Kai 7, D-60590 Frankfurt, Germany. Rickerts@em.uni-frankfurt.de
Abstract
OBJECTIVE: To investigate whether the use of highly active antiretroviral therapy (HAART) is associated with an increased incidence of myocardial infarctions (MI) in HIV infected patients. DESIGN: Retrospective analysis of a cohort of 4993 HIV infected patients treated at our hospital between January, 1 1983 and December, 31 1998. The incidence of myocardial infarctions during 4 observation periods with different antiretroviral treatment strategies are compared. Possible risk factors for MI are evaluated by univariate analysis and using a multiple regression model. RESULTS: 29 patients with MI were diagnosed between 1983 and 1998. The incidence of MI per 1000 patient-years increased from 0.86 (1983-86), 1.14 (1987-90), 0.59 (1991-94) to 3.41 (1995-98) respectively (p = 0.002). Age >40, previous HAART therapy, homo-, or bisexual mode of HIV transmission and previous AIDS diagnosis were significantly associated with MI in univariate analysis. Age >40 and previous HAART therapy remained significantly associated with MI in a multiple regression model. CONCLUSION: The incidence of MI in HIV infected patients increased in our cohort after the introduction of HAART.
OBJECTIVE: To investigate whether the use of highly active antiretroviral therapy (HAART) is associated with an increased incidence of myocardial infarctions (MI) in HIV infectedpatients. DESIGN: Retrospective analysis of a cohort of 4993 HIV infectedpatients treated at our hospital between January, 1 1983 and December, 31 1998. The incidence of myocardial infarctions during 4 observation periods with different antiretroviral treatment strategies are compared. Possible risk factors for MI are evaluated by univariate analysis and using a multiple regression model. RESULTS: 29 patients with MI were diagnosed between 1983 and 1998. The incidence of MI per 1000 patient-years increased from 0.86 (1983-86), 1.14 (1987-90), 0.59 (1991-94) to 3.41 (1995-98) respectively (p = 0.002). Age >40, previous HAART therapy, homo-, or bisexual mode of HIV transmission and previous AIDS diagnosis were significantly associated with MI in univariate analysis. Age >40 and previous HAART therapy remained significantly associated with MI in a multiple regression model. CONCLUSION: The incidence of MI in HIV infectedpatients increased in our cohort after the introduction of HAART.
Authors: Judith S Currier; Jens D Lundgren; Andrew Carr; Daniel Klein; Caroline A Sabin; Paul E Sax; Jeffrey T Schouten; Marek Smieja Journal: Circulation Date: 2008-06-19 Impact factor: 29.690
Authors: Lawrence A Kingsley; Juliana Cuervo-Rojas; Alvaro Muñoz; Frank J Palella; Wendy Post; Mallory D Witt; Matthew Budoff; Lewis Kuller Journal: AIDS Date: 2008-08-20 Impact factor: 4.177
Authors: Cindy Bednasz; Amneris E Luque; Barry S Zingman; Margaret A Fischl; Barbara M Gripshover; Charles S Venuto; Jie Gu; Zekun Feng; Robin DiFrancesco; Gene D Morse; Qing Ma Journal: Curr Vasc Pharmacol Date: 2016 Impact factor: 2.719